HomeCompareOTPBF vs PFE

OTPBF vs PFE: Dividend Comparison 2026

OTPBF yields 2.35% · PFE yields 6.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 OTPBF wins by $131.62M in total portfolio value
10 years
OTPBF
OTPBF
● Live price
2.35%
Share price
$125.00
Annual div
$2.94
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$131.67M
Annual income
$121,727,989.82
Full OTPBF calculator →
PFE
Pfizer Inc.
● Live price
6.13%
Share price
$28.08
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$26,258.71
Full PFE calculator →

Portfolio growth — OTPBF vs PFE

📍 OTPBF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodOTPBFPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, OTPBF + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
OTPBF pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

OTPBF
Annual income on $10K today (after 15% tax)
$199.98/yr
After 10yr DRIP, annual income (after tax)
$103,468,791.35/yr
PFE
Annual income on $10K today (after 15% tax)
$520.66/yr
After 10yr DRIP, annual income (after tax)
$22,319.90/yr
At 15% tax rate, OTPBF beats the other by $103,446,471.44/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of OTPBF + PFE for your $10,000?

OTPBF: 50%PFE: 50%
100% PFE50/50100% OTPBF
Portfolio after 10yr
$65.86M
Annual income
$60,877,124.27/yr
Blended yield
92.44%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

OTPBF
No analyst data
Altman Z
0.7
Piotroski
8/9
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-2.1% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

OTPBF buys
0
PFE buys
8
PoliticianChamberTickerTypeAmountDate
Gilbert Cisneros🏢 House$PFE▲ Buy$1,001 - $15,0002026-02-10
Susan M. Collins🏛 Senate$PFE▲ Buy$15,001 - $50,0002026-02-03
James French Hill🏢 House$PFE▼ Sell$100,001 - $250,0002025-12-31
Gilbert Cisneros🏢 House$PFE▼ Sell$1,001 - $15,0002025-12-19
Ro Khanna🏢 House$PFE▼ Sell$1,001 - $15,0002025-09-15
Ro Khanna🏢 House$PFE▼ Sell$1,001 - $15,0002025-09-05
Gilbert Cisneros🏢 House$PFE▼ Sell$1,001 - $15,0002025-08-05
Lisa McClain🏢 House$PFE▲ Buy$1,001 - $15,0002025-07-16
Ron Wyden🏛 Senate$PFE▼ Sell$1,001 - $15,0002025-06-03
Ron Wyden🏛 Senate$PFE▼ Sell$1,001 - $15,0002025-06-03
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricOTPBFPFE
Forward yield2.35%6.13%
Annual dividend / share$2.94$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%13.2%
Portfolio after 10y$131.67M$49.6K
Annual income after 10y$121,727,989.82$26,258.71
Total dividends collected$130.90M$58.3K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: OTPBF vs PFE ($10,000, DRIP)

YearOTPBF PortfolioOTPBF Income/yrPFE PortfolioPFE Income/yrGap
1← crossover$11,171$470.53$9,153$693.39+$2.0KOTPBF
2$12,935$982.44$8,593$849.25+$4.3KOTPBF
3$15,967$2,126.39$8,336$1,066.78+$7.6KOTPBF
4$21,991$4,906.16$8,437$1,384.80+$13.6KOTPBF
5$36,160$12,630.15$9,013$1,875.40+$27.1KOTPBF
6$77,511$38,819.26$10,306$2,680.72+$67.2KOTPBF
7$238,470$155,533.85$12,820$4,101.38+$225.7KOTPBF
8$1,149,589$894,426.04$17,673$6,826.70+$1.13MOTPBF
9$9,289,397$8,059,337.03$27,543$12,591.86+$9.26MOTPBF
10$131,667,645$121,727,989.82$49,560$26,258.71+$131.62MOTPBF

OTPBF vs PFE: Complete Analysis 2026

OTPBFStock

OTP Bank Nyrt., together with its subsidiaries, provides commercial banking services to retail clients, corporations and agricultural enterprises, and private and institutional investors in Hungary and internationally. It offers current, foreign currency, securities, long term investment, and retirement savings accounts; bank and business cards; agricultural, mortgage, and housing loans, as well as overdraft facilities; and invests in government and fixed income bonds, mutual funds, mortgages, shares, and certificates, stock exchange transaction orders, investment fund shares, and government securities. The company also provides cash management services, such as domestic and international transfers, batch payments, liquidity and savings management, and financing; real estate development, leasing, and management services; wealth planning, commercial factoring, refinancing, finance lease, housing savings, fund management, and e-services; and Internet, mobile phone, SMS, telephone, and private banking services. As of December 31, 2021, it operated through a network of 1,455 branches and 4,697 ATMs. The company was incorporated in 1949 and is based in Budapest, Hungary.

Full OTPBF Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this OTPBF vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

OTPBF vs SCHDOTPBF vs JEPIOTPBF vs OOTPBF vs KOOTPBF vs MAINOTPBF vs JNJOTPBF vs MRKOTPBF vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.